Waiting hours or days for lab test results is a frustration most patients and healthcare providers know all too well. Point-of-care (POC) diagnostics are eliminating that lag – and new data from SNS Insider shows the global market for these tools is set for massive expansion.
The latest SNS Insider report projects the global point-of-care diagnostics market will reach USD 114.65 billion by 2035. This growth reflects a broader shift toward decentralized, patient-centric healthcare that prioritizes speed and accessibility.
For those new to the term: POC diagnostics are medical tests performed at or near the site of patient care, outside traditional central laboratories. Common examples include rapid infectious disease tests, portable glucose monitors, and handheld blood analyzers used in ambulances or rural clinics.
Key Drivers of POC Diagnostics Market Growth
Several interconnected factors are fueling the market’s rise, per the SNS Insider analysis:
- Rising chronic disease burden: Growing rates of diabetes, cardiovascular disease, and infectious illnesses are driving demand for regular, accessible testing.
- Technology advancements: Miniaturization of lab equipment, integration with IoT and smartphone apps, and improved test accuracy are making POC tools more viable for widespread use.
- Decentralized care demand: Patients and providers are prioritizing testing that can be done in doctors’ offices, home settings, and remote areas with limited lab access.
- Healthcare cost savings: Faster test results reduce unnecessary follow-up visits and enable quicker treatment decisions, cutting overall system costs.
Market Segmentation Breakdown
The global POC diagnostics market splits into distinct segments, each with unique growth opportunities:
By Product Type
- Instruments (handheld analyzers, readers)
- Consumables (test strips, reagents, cartridges)
- Software and connectivity solutions
By Application
- Glucose monitoring (largest current segment)
- Infectious disease testing (fastest growing segment)
- Cardiology, oncology, and coagulation testing
By End User
- Hospitals and emergency departments
- Home care settings
- Clinics and physician offices
- Remote and low-resource healthcare sites
Regional Market Trends
Growth won’t be evenly distributed across the globe:
- North America: Currently holds the largest market share, driven by high healthcare spending, strong regulatory support, and early adoption of new POC technologies.
- Asia-Pacific: Expected to register the fastest CAGR through 2035, thanks to expanding healthcare infrastructure, rising chronic disease rates, and growing medical tourism.
- Europe: Steady growth as governments push for decentralized care models to reduce strain on public healthcare systems.
Challenges to Market Expansion
No fast-growing market is without hurdles. Key challenges for POC diagnostics providers include:
- Strict regulatory requirements for medical device approval
- Occasional accuracy gaps compared to central lab testing for complex assays
- High upfront R&D and commercialization costs for new devices
- Shortage of trained personnel to operate advanced POC tools in some regions
Actionable Insights for Stakeholders
What does this growth mean for different players in the healthcare ecosystem?
For healthcare providers: Investing in POC tools can improve patient throughput, reduce wait times, and enable faster treatment for acute conditions.
For investors: Look to companies developing connected POC devices, low-cost tests for emerging markets, and solutions for home-based care.
For patients: Expect more accessible, faster testing options in the coming years, from at-home chronic disease monitoring to rapid diagnostics in urgent care settings.
Final Takeaway
The SNS Insider projection of a USD 114.65 billion point-of-care diagnostics market by 2035 underscores a permanent shift in how medical testing is delivered. As technology improves and demand for accessible care grows, POC tools will become a cornerstone of global healthcare systems.
Whether you’re a provider, investor, or patient, this market growth signals a future where high-quality diagnostic testing is available whenever and wherever it’s needed.
Comments are closed, but trackbacks and pingbacks are open.